Results 241 to 250 of about 64,429 (258)
Some of the next articles are maybe not open access.
Preventing and Treating Anthracycline Cardiotoxicity: New Insights
Annual Review of Pharmacology and Toxicology, 2021Alessandra Ghigo +2 more
exaly
Sustained alternate-day fasting potentiates doxorubicin cardiotoxicity
Cell Metabolism, 2023Ali Javaheri
exaly
Anthracycline-induced cardiotoxicity — are we about to clear this hurdle?
European Journal of Cancer, 2023Rafal Zielinski, Sandra Silberman
exaly
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
Ca-A Cancer Journal for Clinicians, 2016Carmen Criscitiello
exaly
Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors
Annals of Oncology, 2012Josep Tabernero Caturla +2 more
exaly
Early cardiotoxicity of the CHOP regimen in aggressivenon-Hodgkin’s lymphoma
Annals of Oncology, 2003Eric Deconinck, S Limat
exaly
Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor–Related Cardiotoxicity
Circulation, 2017Fabrice Barlesi, Nausicaa Malissen
exaly
cTnT can be a useful marker for early detection of anthracycline cardiotoxicity
Annals of Oncology, 2005İsmail Çelik, Sercan Aksoy, G Tekuzman
exaly
Cancer Therapy–Induced Cardiotoxicity: Basic Mechanisms and Potential Cardioprotective Therapies
Journal of the American Heart Association, 2014exaly